Literature DB >> 23404249

[Compliance of patients undergoing thromboprophylaxis with enoxaparin: the COMFORT study].

S Rübenacker1, J Kaiser, M Guschmann.   

Abstract

Venous thromboembolism and subsequent pulmonary embolism are frequent and sometimes fatal complications in patients after surgical interventions. To prevent thromboembolisms an effective prophylaxis is necessary and outpatients in particular need adequate compliance. The aim of the prospective non-interventional study COMFORT was to analyze 8,091 outpatients after surgical and orthopedic interventions with different risk profiles with respect to factors affecting patient compliance in a positive or negative way. The follow-up period was 14 days and 92.5 % of the patients took the medication for the prescribed duration, 2.1 % (n = 166) terminated the medication too early and no information was available for 5.9 % (n = 442) of the patients. The reasons given for the premature termination of the injections were no more need for prophylaxis and end of medication by order of the physician due to mobilization or adverse events. Of the patients 73 % stated that the administartion was simple and without any problems and the majority of patients recognized injection as the administration mode of low molecular weight heparin to be the most important medication. The findings of this study can contribute to a better understanding of patient compliance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404249     DOI: 10.1007/s00104-012-2443-2

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  13 in total

1.  [Prevention of deep vein thrombosis in surgical departments].

Authors:  S Haas
Journal:  Chirurg       Date:  2004-03       Impact factor: 0.955

2.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

3.  Thromboembolism after foot and ankle surgery. A multicenter study.

Authors:  M S Mizel; H T Temple; J D Michelson; R G Alvarez; T O Clanton; C C Frey; A P Gegenheimer; S R Hurwitz; L D Lutter; M G Mankey; R A Mann; R A Miller; E G Richardson; L C Schon; F M Thompson; M L Yodlowski
Journal:  Clin Orthop Relat Res       Date:  1998-03       Impact factor: 4.176

4.  Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients.

Authors:  M D Stringer; C A Steadman; A R Hedges; E M Thomas; T R Morley; V V Kakkar
Journal:  J Bone Joint Surg Br       Date:  1989-05

5.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

Review 6.  Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.

Authors:  K Wellington; K McClellan; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  [Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].

Authors:  H J Kock; K P Schmit-Neuerburg; J Hanke; A Terwort; G Rudofsky; H Hirche
Journal:  Unfallchirurgie       Date:  1994-12

8.  Incidence of deep vein thrombosis after arthroscopic knee surgery: a prospective study.

Authors:  J S Williams; M J Hulstyn; P D Fadale; P B Lindy; M G Ehrlich; J Cronan; G Dorfman
Journal:  Arthroscopy       Date:  1995-12       Impact factor: 4.772

Review 9.  [Thrombosis prophylaxis in surgery. What is the evidence?].

Authors:  S Haas; A Encke; R Krauspe; C Waydhas
Journal:  Chirurg       Date:  2011-12       Impact factor: 0.955

10.  Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

Authors:  T Pullar; A J Birtwell; P G Wiles; A Hay; M P Feely
Journal:  Clin Pharmacol Ther       Date:  1988-11       Impact factor: 6.875

View more
  4 in total

1.  The ABC taxonomy for medication adherence translated into French and German.

Authors:  Melanie Haag; Audrey Lehmann; Kurt E Hersberger; Marie-Paule Schneider; Aurélie Gauchet; Bernard Vrijens; Isabelle Arnet; Benoît Allenet
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

2.  Continuation of venous thromboembolism prophylaxis after hospital discharge into the outpatient setting: the ACCEPT study.

Authors:  Sebastian M Schellong; Jürgen Kaiser; Peter Bramlage
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

3.  Assessment of Saudi Women's Adherence and Experience with Venous Thromboembolism Prophylaxis after Cesarean Section Delivery Using Telemedicine Technology.

Authors:  Dalia Ahmed Elmaghraby; Zakiah Khalid Al-Bassri; Zainab Ahmed AlTuraiki; Jinan Adnan Alsaleh; Latifah Saleh Alzuwayyid; Norah Abdulmohsen Albanyan; Abdulaziz Saleh Almulhim
Journal:  Appl Bionics Biomech       Date:  2022-03-14       Impact factor: 1.781

4.  The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery.

Authors:  Yuan Gao; Anhua Long; Zongyan Xie; Yutong Meng; Jing Tan; Houchen Lv; Licheng Zhang; Lihai Zhang; Peifu Tang
Journal:  Springerplus       Date:  2016-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.